Uso de antídotos en un servicio de urgencias pediátricas.

dc.contributor.authorMartínez Sánchez, Lidia
dc.contributor.authorAlmario Hernández, A.F.
dc.contributor.authorEscuredo Argullós, Laura
dc.contributor.authorMaçao, P.
dc.contributor.authorTrenchs Sainz de la Maza, Victoria
dc.contributor.authorLuaces Cubells, Carles
dc.date.accessioned2018-10-10T16:29:40Z
dc.date.available2018-10-10T16:29:40Z
dc.date.issued2014-10-01
dc.date.updated2018-10-10T16:29:40Z
dc.description.abstractINTRODUCTION: Poisoning is an infrequent cause of consultation in a pediatric emergency department (PED), but it can be potentially serious. Pediatricians should know how to use the available antidotes properly. OBJECTIVES: To analyze the use of antidotes in a PED and to assess the suitability of their indications. MATERIALS AND METHODS: A retrospective review of antidote use in a PED between January 2008 and June 2012. Inclusion criteria were age younger than 18 years and consultation for suspicious poisoning by a substance that could be treated with an antidote. The adequacy of antidote indication was based on the recommendations of the Spanish Society of Pediatric Emergencies (SSPE). RESULTS: A total of 1728 consultations for suspicious poisoning (0.4% of the total visits in the PED) were recorded. In 353 cases (20.4%) the involved poison could be treated with an antidote. Sixty-seven patients received an antidote (3.9% of consultations for suspicious poisoning), and a total of 69 administrations of an antidote were made: 100% oxygen (46), N-acetylcysteine (10), flumazenil (4), naloxone (3), deferoxamine (2), vitamin K (2), bicarbonate (1), and carnitine (1). In 3 cases there was no indication for administration: flumazenil without respiratory depression, and vitamin K following coumarin exposure. As side effects, agitation was noted after the use of flumazenil, and a decrease in the prothrombin time during infusion of N-acetylcysteine. CONCLUSIONS: The administration of antidotes in this PED is uncommon and, mainly, in accordance with the SSPE recommendations, and without serious side effects. The use of flumazenil needs to be limited to the cases with a clear indication and without any contraindication.
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec648136
dc.identifier.issn1695-4033
dc.identifier.pmid24439102
dc.identifier.urihttps://hdl.handle.net/2445/125276
dc.language.isospa
dc.publisherElsevier
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.anpedi.2013.12.002
dc.relation.ispartofAnales de Pediatria, 2014, vol. 81, num. 4, p. 220-225
dc.relation.urihttps://doi.org/10.1016/j.anpedi.2013.12.002
dc.rights(c) Asociación Española de Pediatría, 2014
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
dc.subject.classificationUrgències en pediatria
dc.subject.classificationAntídots
dc.subject.classificationIntoxicació
dc.subject.classificationInfants
dc.subject.otherPediatric emergencies
dc.subject.otherAntidotes
dc.subject.otherPoisoning
dc.subject.otherChildren
dc.titleUso de antídotos en un servicio de urgencias pediátricas.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
648136.pdf
Mida:
431.94 KB
Format:
Adobe Portable Document Format